Sentences with phrase «for therapeutic cancer vaccines»

Telomerase is being explored as a target for therapeutic cancer vaccines.

Not exact matches

On the morning of Monday, October 3, the Nobel Committee announced that immunologist Ralph Steinman had won the Nobel Prize in Medicine for his work on immune cells and a discovery that led to the first therapeutic cancer vaccine.

One of the most contentious and closely scrutinized decisions before the FDA concerns Provenge, a proposed therapeutic vaccine made by Dendreon for use against prostate cancer.

Currently there are only a few approved therapeutic cancer vaccines, none of which are approved for the treatment of GBM.

A new therapeutic vaccine, GTL001, developed by Genticel to clear HPV strains 16 and 18 — the types most likely to cause cancer — is being evaluated for safety in a Phase I clinical trial at the University of Louisville.

The second focus on my research is the development of novel therapeutic vaccine approaches for cancer.

Current immunotherapies for ovarian cancer fall into six broad categories: monoclonal antibodies; checkpoint inhibitors and immune modulators; therapeutic vaccines; adoptive T cell transfer; oncolytic viruses; and adjuvant immunotherapies.

Those selected for funding range from an antibacterial coating for orthopedic implants to a novel nano - vaccine technology to a potential next - generation cancer therapeutic.

Oncophage, the therapeutic vaccine for kidney cancer developed by Pramod Srivastava, is approved in Russia, making it the first therapeutic vaccine worldwide to be approved for patients.

The trial was part of the Cancer Vaccine Collaborative, a joint program between the Cancer Research Institute and the Ludwig Institute for Cancer Research to develop therapeutic cancer vacCancer Vaccine Collaborative, a joint program between the Cancer Research Institute and the Ludwig Institute for Cancer Research to develop therapeutic cancer vacCancer Research Institute and the Ludwig Institute for Cancer Research to develop therapeutic cancer vacCancer Research to develop therapeutic cancer vaccancer vaccines.

Her work focuses on using RNA vaccines for Leishmaniasis and prostate cancer to generate protective or therapeutic immune responses in mouse models and evaluate in an artificial lymph node system.

Cervical cancer is often deadly when it recurs and physician scientists want to know if a new therapeutic vaccine can prevent or reduce recurrence in women at high risk for its return.

We have validated the glycosphingolipid - binding non-toxic B - subunit of Shiga toxin as a delivery tool for cancer immunotherapy, and are currently building therapeutic vaccine prototypes for breast and head - and - neck cancers.

Current immunotherapies for colorectal cancer fall into seven broad categories: checkpoint inhibitors and immune modulators, monoclonal antibodies, therapeutic vaccines, adoptive cell therapy, oncolytic virus therapy, adjuvant immunotherapies, and cytokines.

Through the CIC program, the Cancer Research Institute conducts a number of important initiatives that seek among other things to build consensus across the field on key issues, to develop and implement new standards for carrying out and reporting immunological monitoring assays of therapeutic cancer vaccines, and to establish and promote the adoption of new criteria for evaluating the clinical impact of cancer immunotherCancer Research Institute conducts a number of important initiatives that seek among other things to build consensus across the field on key issues, to develop and implement new standards for carrying out and reporting immunological monitoring assays of therapeutic cancer vaccines, and to establish and promote the adoption of new criteria for evaluating the clinical impact of cancer immunothercancer vaccines, and to establish and promote the adoption of new criteria for evaluating the clinical impact of cancer immunothercancer immunotherapies.

Most recently, CRI has launched a new «venture philanthropy» program called the Cancer Vaccine Acceleration Fund (CVAF) as a means to catalyze development of next - generation therapeutic cancer vaccines and other immunotherapies by helping to address the critical shortage of capital available for early stage clinical tCancer Vaccine Acceleration Fund (CVAF) as a means to catalyze development of next - generation therapeutic cancer vaccines and other immunotherapies by helping to address the critical shortage of capital available for early stage clinical tcancer vaccines and other immunotherapies by helping to address the critical shortage of capital available for early stage clinical trials.

Physicians with the Personalized Medicine Program at The Tisch Cancer Institute have initiated a phase I proof - of - concept study, a fully personalized multipeptide therapeutic vaccine designed to target tumor - derived neoantigens for individual patients.

It is focused on the development of preventive and therapeutic vaccine products and cancer drugs for patients with unmet medical needs.